140 related articles for article (PubMed ID: 24435157)
1. [Structured diagnostics and therapy of the CUP syndrome].
Löffler H; Neben K; Krämer A
Radiologe; 2014 Feb; 54(2):112-6. PubMed ID: 24435157
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
3. Carcinomas of an unknown primary origin--diagnosis and treatment.
Massard C; Loriot Y; Fizazi K
Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
[TBL] [Abstract][Full Text] [Related]
4. Improving survival in metastatic carcinoma of unknown origin.
Brigden ML; Murray N
Postgrad Med; 1999 May; 105(5):63-4, 67-74. PubMed ID: 10335321
[TBL] [Abstract][Full Text] [Related]
5. [CUP syndrome-diagnostics from the perspective of pathology].
Pauli C
Radiologie (Heidelb); 2023 May; 63(5):336-345. PubMed ID: 37079060
[TBL] [Abstract][Full Text] [Related]
6. [The big mystery].
Delorme S; Jäger D
Radiologe; 2014 Feb; 54(2):106. PubMed ID: 24493101
[No Abstract] [Full Text] [Related]
7. Update on the diagnosis of cancer of unknown primary (CUP) origin.
Ariza A; Balañá C; Concha Á; Hitt R; Homet B; Matilla A; Alba E
Clin Transl Oncol; 2011 Jul; 13(7):434-41. PubMed ID: 21775269
[TBL] [Abstract][Full Text] [Related]
8. [The role of pathology in the diagnostics of CUP syndrome].
Stenzinger A; Kriegsmann M; Weichert W
Radiologe; 2014 Feb; 54(2):124-33. PubMed ID: 24463713
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
Greco FA
Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Pentheroudakis G; Briasoulis E; Kalofonos HP; Fountzilas G; Economopoulos T; Samelis G; Koutras A; Karina M; Xiros N; Samantas E; Bamias A; Pavlidis N;
Acta Oncol; 2008; 47(6):1148-55. PubMed ID: 18607872
[TBL] [Abstract][Full Text] [Related]
11. Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.
Amela EY; Lauridant-Philippin G; Cousin S; Ryckewaert T; Adenis A; Penel N
Crit Rev Oncol Hematol; 2012 Nov; 84(2):213-23. PubMed ID: 22503530
[TBL] [Abstract][Full Text] [Related]
12. [Cancer of unknown primary-The new ESMO guidelines].
Bochtler T; Pouyiourou M; Krämer A
Radiologie (Heidelb); 2023 May; 63(5):329-335. PubMed ID: 36930265
[TBL] [Abstract][Full Text] [Related]
13. [Metastases with CUP syndrome].
Seeber S; Strumberg D
Urologe A; 2006 May; 45(5):614-9. PubMed ID: 16710679
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
15. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
Pentheroudakis G; Greco FA; Pavlidis N
Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817
[TBL] [Abstract][Full Text] [Related]
16. [Radiological diagnostics in CUP syndrome].
Kazmierczak PM; Nikolaou K; Rominger A; Graser A; Reiser MF; Cyran CC
Radiologe; 2014 Feb; 54(2):117-23. PubMed ID: 24500247
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin.
Alexandraki KI; Tsoli M; Kyriakopoulos G; Angelousi A; Nikolopoulos G; Kolomodi D; Kaltsas GA
Minerva Endocrinol; 2019 Dec; 44(4):378-386. PubMed ID: 30991795
[TBL] [Abstract][Full Text] [Related]
18. Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.
Yildirim M; Müller von der Grün J; Winkelmann R; Fokas E; Rödel F; Ackermann H; Rödel C; Balermpas P
Strahlenther Onkol; 2017 Apr; 193(4):305-314. PubMed ID: 28144684
[TBL] [Abstract][Full Text] [Related]
19. Cancer of unknown primary.
Lee MS; Sanoff HK
BMJ; 2020 Dec; 371():m4050. PubMed ID: 33288500
[TBL] [Abstract][Full Text] [Related]
20. Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.
Legué LM; van Erning FN; Bernards N; Lemmens VEPP; de Hingh IHJT; Creemers GJ
Target Oncol; 2019 Dec; 14(6):699-705. PubMed ID: 31625001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
